Delivery Order SPE2DB24D2205-SPE2DB25FEDHM
Award Date
6/5/25
Potential Completion Date
6/27/25
Potential Value
$3.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,934.50 firm fixed-price delivery order is for the supply of 90-count tablets of the drug Esbriet (pirfenidone) 801 mg. The award has an ultimate completion date of December 3, 2024 and was issued on November 8, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division, a major pharmaceutical distribution company. The contract, valued at up to $3,311.50, is for the delivery of the prescription medication Esbriet (pirfenidone) 801 mg tablets. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued up to $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $3,311.50 firm fixed-price delivery order is for the supply of 4,565,099 units of the prescription medication Esbriet (pirfenidone) 801 mg tablets. The contract has an ultimate completion date of July 30, 2024 and does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,851.90 firm fixed-price delivery order is for the supply of 4,568,160,448 tablets of the medication Esbriet 267 mg. The contract has a performance period through May 28, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $3,425.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the prescription medication Esbriet 267 mg tablets, with a performance period extending through May 7, 2025. The contract is a Firm Fixed Price Delivery Order and is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Esbriet 267 mg tablets, a pharmaceutical product, with a ceiling value of $3,425.95 and a period of performance through June 25, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug...
This federal contract award, valued at $3,425.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of Esbriet 801 mg tablets. The contract has a firm fixed price pricing type and an ultimate completion date of May 6, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, to supply Esbriet 801 mg tablets to the government. The Delivery Order, valued at $3,311.50, has a firm fixed price and an ultimate completion date of July 24, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as...
This federal contract award was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $3,425.95 firm fixed-price delivery order contract covers the supply of ESBRIET 267 MG TABLET 270S, a pharmaceutical product. The contract has an ultimate completion date of January 23, 2025 and was awarded on December 31, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This contract award, valued at $3,425.95, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Esbriet 801 mg tablets, a pharmaceutical product, with a completion date of February 5, 2025. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...